The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to develo** treatment
A Emami Nejad, S Najafgholian, A Rostami… - Cancer Cell …, 2021 - Springer
Hypoxia is a common feature of solid tumors, and develops because of the rapid growth of
the tumor that outstrips the oxygen supply, and impaired blood flow due to the formation of …
the tumor that outstrips the oxygen supply, and impaired blood flow due to the formation of …
Versatile role of curcumin and its derivatives in lung cancer therapy
Lung cancer is a main cause of death all over the world with a high incidence rate.
Metastasis into neighboring and distant tissues as well as resistance of cancer cells to …
Metastasis into neighboring and distant tissues as well as resistance of cancer cells to …
Emerging links between endosomal pH and cancer
Extracellular acidification is a well-known driver of tumorigenesis that has been extensively
studied. In contrast, the role of endosomal pH is novel and relatively unexplored. There is …
studied. In contrast, the role of endosomal pH is novel and relatively unexplored. There is …
The role of plasma membrane sodium/hydrogen exchangers in gastrointestinal functions: proliferation and differentiation, fluid/electrolyte transport and barrier integrity
K Nikolovska, UE Seidler, C Stock - Frontiers in Physiology, 2022 - frontiersin.org
The five plasma membrane Na+/H+ exchanger (NHE) isoforms in the gastrointestinal tract
are characterized by distinct cellular localization, tissue distribution, inhibitor sensitivities …
are characterized by distinct cellular localization, tissue distribution, inhibitor sensitivities …
Analysis of single extracellular vesicles for biomedical applications with especial emphasis on cancer investigations
Extracellular vesicles (EVs) are lipid membrane enclosed nano-sized vesicles that are
secreted by all known organisms. These vesicles are increasingly recognized as important …
secreted by all known organisms. These vesicles are increasingly recognized as important …
[HTML][HTML] DNA damage and metabolic mechanisms of cancer drug resistance
D Tiek, SY Cheng - Cancer Drug Resistance, 2022 - ncbi.nlm.nih.gov
Cancer drug resistance is one of the main barriers to overcome to ensure durable treatment
responses. While many pivotal advances have been made in first combination therapies …
responses. While many pivotal advances have been made in first combination therapies …
SP1 transcriptionally activates NLRP6 inflammasome and induces immune evasion and radioresistance in glioma cells
Y Yu, F Cao, Y **ong, H Zhou - International immunopharmacology, 2021 - Elsevier
Glioma accounts for approximately 80% of all malignant brain tumors. This study aimed to
investigate the interaction between specificity protein 1 (SP1) and NLR family pyrin domain …
investigate the interaction between specificity protein 1 (SP1) and NLR family pyrin domain …
Long non-coding RNA GABPB1-AS1 augments malignancy of glioma cells by sequestering microRNA-330 and reinforcing the ZNF367/cell cycle signaling pathway
X Li, H Wang - Neuropsychiatric disease and treatment, 2021 - Taylor & Francis
Background Deregulation of long non-coding RNAs (lncRNAs) is frequently relevant to the
malignant phenotypical changes. This study aimed to explore the role of lncRNA GABPB1 …
malignant phenotypical changes. This study aimed to explore the role of lncRNA GABPB1 …
The role of aquaporin 4 in brain tumors: implications for pathophysiology, diagnosis and therapy
M Behnam, A Motamedzadeh, M Aalinezhad… - Molecular Biology …, 2022 - Springer
Primary brain tumors are a heterogeneous group of tumors that arise from cells intrinsic to
the central nervous system (CNS). Aquaporin-4 (AQP4) has been implicated in the …
the central nervous system (CNS). Aquaporin-4 (AQP4) has been implicated in the …
Fabrication of marizomib-loaded zeolitic imidazolate framework-8@ manganese dioxide for promising drug delivery system of glioma cancer cells
J **g, Q Meng, AH Hirad, MK Ramar - Process Biochemistry, 2023 - Elsevier
Marizomib is a novel, irreversible, brain-penetrant pan-proteasome inhibitor with
encouraging findings in preclinical models and early-stage clinical trials for patients with …
encouraging findings in preclinical models and early-stage clinical trials for patients with …